Agios Pharmaceuticals, Inc. SEC filings AGIO
Agios Pharmaceuticals, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Dec 7, 2015. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jun 24, 2024 | — |
| CORRESP | Letter to the SEC | Jun 11, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| CT ORDER | Filing | Sep 10, 2021 | — |
| POSASR | Filing | Apr 30, 2020 | — |
| CT ORDER | Filing | Jul 16, 2019 | — |
| CT ORDER | Filing | Apr 26, 2019 | — |
| CT ORDER | Filing | Apr 26, 2019 | — |
| CT ORDER | Filing | Aug 24, 2018 | — |
| CT ORDER | Filing | Aug 21, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2018 | — |
| CORRESP | Letter to the SEC | Jul 13, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2017 | — |
| CORRESP | Letter to the SEC | Aug 11, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2017 | — |
| CT ORDER | Filing | Sep 21, 2016 | — |
| CT ORDER | Filing | Jun 9, 2016 | — |
| CT ORDER | Filing | Jun 9, 2016 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AGIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1439222
- Former names
- AGIOS PHARMACEUTICALS INC (until Jul 16, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.